Article Information
History
- April 29, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Andrew Ip, MD, MS1,
- Kaushal Parikh, MBBS3,
- Joseph E. Parrillo, MD3,4,
- Shivam Mathura, BA2,
- Eric Hansen, BS, MS2,
- Ihor S. Sawczuk, MD3,4,5 and
- Stuart L. Goldberg, MD1,4,*
- 1Division of Outcomes and Value Research, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ, USA
- 2COTA, Boston, MA, USA
- 3Hackensack University Medical Center, Hackensack, NJ, USA
- 4Hackensack Meridian School of Medicine at Seton Hall University, Nutley, NJ, USA
- 5Hackensack Meridian Health, Edison, NJ, USA
- ↵*Correspondence for this brief report (word limit 600, reference limit 6) should be addressed to Dr. Stuart L. Goldberg (stuart.goldberg{at}hackensackmeridian.org)
Posted April 29, 2020.
Hypertension and Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
